Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Clinical trial NCT04430517 · COMPLETED

Trial details

NCT number: NCT04430517
Sponsor: Mclean Hospital
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment Mild Alzheimer Disease

Start date: 2022-03-02
Primary completion: 2026-04-29
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.